Marta Guix
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Carlos L. ArteagaCammie RinehartTeresa C. DuggerJeffrey A. EngelmanMarianela Pérez-TorresChristoph A. RitterJoaquim BellmuntShizhen Emily Wang
- Topics
- Lung Cancer Treatments and Mutations (9 papers)HER2/EGFR in Cancer Research (8 papers)Renal cell carcinoma treatment (6 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- SpainUnited StatesCanada
In The Last Decade
Marta Guix
43 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 89
- Oncology 1.4k
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 714
- Cancer Research 599
- Radiology, Nuclear Medicine and Imaging 398
Countries citing papers authored by Marta Guix
This map shows the geographic impact of Marta Guix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Guix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Guix more than expected).
Fields of papers citing papers by Marta Guix
This network shows the impact of papers produced by Marta Guix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Guix. The network helps show where Marta Guix may publish in the future.
Co-authorship network of co-authors of Marta Guix
This figure shows the co-authorship network connecting the top 25 collaborators of Marta Guix. A scholar is included among the top collaborators of Marta Guix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Guix. Marta Guix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 5 | |
| 4 | 12 | |
| 5 | 21 | |
| 6 | 20 | |
| 7 | 7 | |
| 8 | 255 | |
| 9 | 38 | |
| 10 | 197 | |
| 11 | 141 | |
| 12 | 34 | |
| 13 | 455 | |
| 14 | 16 | |
| 15 | 3 | |
| 16 | 50 | |
| 17 | 290 | |
| 18 | 388 | |
| 19 | 80 | |
| 20 | 110 |
About Marta Guix
Marta Guix is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 43 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (8 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (599 citations) and Pulmonary and Respiratory Medicine (714 citations). Marta Guix has collaborated with scholars based in Spain, United States and Canada. Frequent co-authors include Carlos L. Arteaga, Cammie Rinehart, Teresa C. Dugger, Jeffrey A. Engelman, Marianela Pérez-Torres, Christoph A. Ritter, Joaquim Bellmunt, Shizhen Emily Wang, Maria G. Olivares and Youngchul Song. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.